home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

Diagnostics & Biomarkers Asia

 
  September 04, 2012  
     
 
IBC Asia, Grand Hyatt Shanghai, China
29 Oct - 1 Nov 2012


Event Highlights
  • Development & Commercialisation of Diagnostics & Biomarkers in Asia
  • Partnership & Investment Opportunities
  • Collaboration & Advances in Personalised Healthcare & Companion Diagnostics
  • Innovations & Technology Breakthroughs: Partnering & Investment Showcase
  • Diagnostic & Prognostic Biomarkers
  • Molecular Diagnostics
  • Point of Care Diagnostics
  • Market Development & Growth Strategies
  • For more details, please refer to  http://www.diagnostics-biomarkersasia.com/agenda.php 
 
 
Organized by: IBC Asia
Invited Speakers:
 
   Dr. Axel Polack, General Partner, TVM Capital, Germany
 
   Aris Constantinides, Founder and Investment Director, NBGI Ventures, UK
           
         Philippe Jacon, CEO, Foundation for Innovative New Diagnostics   (FIND), Switzerland      

Dr. Yin Qiman, Regulatory Affairs Director – Greater China, Beckman Coulter, China

Dr. Simon Harworth, CEO, CompanDX & Founder Director, Team Kapital, UK

Dr. Mingde Xia, Senior Director, Johnson & Johnson Corporate Office of Science and Technology, China

Dr. Victor Shi, President, Asia Pacific, Qiagen, China

Dr. Simon Harworth, CEO, CompanDX & Founder Director, Team Kapital, UK

Kelvin Shao, VP of Marketing Development Center, Shanghai NewSummit Biopharma Group, China

Dr. Jian Han, Faculty Investigator, HudsonAlpha Institute for Biotechnology; CEO, iRepertoire; President & CSO, iCubate, USA

Dr. Thomas Li, Senior Director, US Chief Technology Office & Head of Asia Pacific Technology Management, Roche Diagnostics, USA

Dr. Kfir Oved, CTO, MeMed Diagnostics, Israel

Dr. Anthony Warford, Senior Lecturer in Cellular Pathology,School of Life Sciences, University of Westminster, UK

Dr. Chi-Meng Tzeng, Executive Director and Full Professor,Translational Medicine Research Center, School of Pharmaceutical Sciences, Xiamen University, China; Chairman, Board of Technology, RBC Bioscience, BSI Biotech & VivaCell

Prof. Michael Yang, Chair Professor, Department of Biology and Chemistry; Director, Biotech and Health Centre, City University of Hong Kong and Co-founder & Director, Multigene Diagnostics, Hong Kong

Dr. Chris Pak, President & CEO, Molecular Targeting Technologies Inc, USA

Dr. Huimin Kong, President & CEO, BioHelix Corp, USA

Ashini Fernando, Staff Scientist, BD, Singapore

Dr. Jonathan O’Halloran, Co-founder & CSO, QuantuMDx, UK

 

 
Deadline for Abstracts: NIL
 
Registration:

To register, please visit

http://www.diagnostics-biomarkersasia.com/pricing-registration.php

E-mail: leiching.yew@ibcasia.com.sg
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.